Evidence map›Paper›PMID 41748780›Full record

ArticleScientific reports2026

Association between steatotic liver disease and post-traumatic stress symptoms in the Fukushima health management survey.

Fumikazu Hayashi, Tetsuya Ohira, Atsushi Takahashi, Yuka Ueda, Hironori Nakano, Kanako Okazaki, Masanori Nagao, Shiho Sato, Masaharu Maeda, Itaru Miura and 5 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Fumikazu HayashiRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan. fhayashi@fmu.ac.jp.
Tetsuya OhiraRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.
Atsushi TakahashiRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.
Yuka UedaRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.
Hironori NakanoRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.
Kanako OkazakiRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.
Masanori NagaoRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.
Shiho SatoRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.
Masaharu MaedaRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.
Itaru MiuraRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.
Michio ShimabukuroRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.
Akira SakaiRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.
Junichiro James KazamaRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.
Hitoshi OhtoRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.
Seiji YasumuraRadiation Medical Science Center for the Fukushima Health Management Survey, Fukushima Medical University, 1 Hikariga-oka, Fukushima City, 960-1295, Fukushima, Japan.

Funding

he National Health Fund for Children and Adults Affected by the Nuclear Incident N/AJapan Society for the Promotion of Science JP23K10801
6 · The paper itself

Abstract

We investigated the association of steatotic liver disease (SLD) and metabolic dysfunction-associated SLD (MASLD) with the occurrence of post-traumatic stress symptoms (PTSS) after the Great East Japan Earthquake in participants of the Fukushima Health Management Survey (FMHS), a cohort that was initiated after the disaster. This cohort study used data from the FMHS (2011–2018) and included 16,392 participants aged 40–90 years (7505 men and 8,887 women) who were able to be assessed for PTSS. SLD was defined by the fatty liver index. To further identify the association between PTSS and SLD/MASLD, Cox regression models were used to estimate hazard ratios and 95% confidence interval (CI) for PTSS. Results of multivariable Cox regression modeling for the entire participant population revealed that SLD (hazard ratio: 1.109, 95% CI: 1.002–1.227) had a significant positive association with the occurrence of PTSS. In the multivariate Cox regression model incorporating SLD classification, MASLD (1.154 [1.036–1.286]) was significantly positively associated with the occurrence of PTSS. This study suggests that SLD/MASLD may be a risk for the development of PTSS after a disaster.

Indexed as

Fatty LiverFukushima Nuclear AccidentStress Disorders, Post-TraumaticAdultAgedAged, 80 and overEarthquakesFemaleHealth SurveysHumansJapanMaleMiddle AgedProportional Hazards ModelsFatty liver indexFukushima Health Management SurveyGreat East Japan EarthquakeMetabolic dysfunction-associated steatotic liver diseasePost-traumatic stress symptomSteatotic liver disease

Identifiers

PMID41748780
PMCPMC13046763

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.